Impact of Community Respiratory Viral Infections in Urban Children with Asthma
-
2019/02/01
-
Details
-
Personal Author:Batterman SA ; Brennan SR ; Comstock AT ; Eder BN ; Goldsmith AM ; Hershenson MB ; Lewis TC ; Mentz GB ; Metitiri EE ; Mukherjee B ; Owens KB ; Ren X ; Ricci JM ; Robins TG ; Walsh MP ; Washington GL ; Wicklund KE
-
Corporate Authors:
-
Description:Background: Upper respiratory tract viral infections cause asthma exacerbations in children. However, the impact of natural colds on children with asthma in the community, particularly in the high-risk urban environment, is less well defined. Objective: We hypothesized that children with high-symptom upper respiratory viral infections have reduced airway function and greater respiratory tract inflammation than children with virus-positive low-symptom illnesses or virus-negative upper respiratory tract symptoms. Methods: We studied 53 children with asthma from Detroit, Michigan, during scheduled surveillance periods and self-reported respiratory illnesses for 1 year. Symptom score, spirometry, fraction of exhaled nitric oxide (FeNO), and nasal aspirate biomarkers, and viral nucleic acid and rhinovirus (RV) copy number were assessed. Results: Of 658 aspirates collected, 22.9% of surveillance samples and 33.7% of respiratory illnesses were virus-positive. Compared with the virus-negative asymptomatic condition, children with severe colds (symptom score =5) showed reduced forced expiratory flow at 25% to 75% of the pulmonary volume (FEF25%-75%), higher nasal messenger RNA expression of C-X-C motif chemokine ligand (CXCL)-10 and melanoma differentiation-associated protein 5, and higher protein abundance of CXCL8, CXCL10 and C-C motif chemokine ligands (CCL)-2, CCL4, CCL20, and CCL24. Children with mild (symptom score, 1-4) and asymptomatic infections showed normal airway function and fewer biomarker elevations. Virus-negative cold-like illnesses demonstrated increased FeNO, minimal biomarker elevation, and normal airflow. The RV copy number was associated with nasal chemokine levels but not symptom score. Conclusion: Urban children with asthma with high-symptom respiratory viral infections have reduced FEF25%-75% and more elevations of nasal biomarkers than children with mild or symptomatic infections, or virus-negative illnesses. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1081-1206
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:122
-
Issue:2
-
NIOSHTIC Number:nn:20055187
-
Citation:Ann Allergy Asthma Immunol 2019 Feb; 122(2):175-183.e2
-
Contact Point Address:Marc B. Hershenson, MD, University of Michigan Medical School, 1150 W. Medical Center Dr., Building MSRB2, Room 3570B, Ann Arbor, MI 48109-5688
-
Email:mhershen@umich.edu
-
Federal Fiscal Year:2019
-
Performing Organization:University of Michigan, Ann Arbor
-
Peer Reviewed:True
-
Start Date:20050701
-
Source Full Name:Annals of Allergy, Asthma and Immunology
-
End Date:20280630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:b83e165a141271e5cfbdd8477062c881ba2bc1e5a8b17f70725769bd47c5f450e09985e5ceac7560e3c4c076ecbfee9ac0b27d826ec519a81d65c668c0ab789d
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like